Increased bioactive TNF in human systemic lupus erythematosus: associations with cell death
- 1 February 2002
- journal article
- research article
- Published by SAGE Publications in Lupus
- Vol. 11 (2), 102-108
- https://doi.org/10.1191/0961203302lu160oa
Abstract
In systemic lupus erythematosus (SLE) serum TNF is increased and correlates with its soluble receptors and with disease activity. We therefore investigated (i) whether the TNF in SLE serum is bioactive, (ii) whether SLE cells react to TNF and (iii) whether there are associations with cell death, which is regarded as pathogenic in SLE. Sera from active SLE patients induced an increase in fibroblast CD54, which was abolished by blocking antibodies against TNF, suggesting TNF bioactivity. SLE lymphocytes had a similar surface expression of TNF-R I as healthy lymphocytes, their expression of TNF-R II was slightly increased. Recombinant TNF induced cell death in PBMC of SLE patients, suggesting functional receptors. Serum levels of sTNF-RII (as a surrogate marker for TNF activity) correlated with sTNF-RI and disease activity, as expected, and also correlated with the percentage of dying lymphocytes and with lymphocytic CD95. SLE sera contain increased amounts of biologically active TNF. Peripheral blood lymphocytes of SLE patients express functional TNF receptors. Finally, associations with cell death and CD95 receptors suggest that TNF may be pathogenic in SLE.This publication has 35 references indexed in Scilit:
- Cytokine regulation of apoptosis and Bcl-2 expression in lymphocytes of patients with systemic lupus erythematosusCell Death & Differentiation, 2000
- Serum IL-6, TNFα, p55 srTNFα, p75 srTNFα, srIL-2α Levels and Disease Acitivity in Systemic Lupus ErythematosusClinical Rheumatology, 1999
- Induction of apoptosis in mature T cells by tumour necrosis factorNature, 1995
- The apoptosis-1/Fas protein in human systemic lupus erythematosus.JCI Insight, 1994
- Up‐regulation by tumor necrosis factor α of intercellular adhesion molecule 1 expression and function in synovial fibroblasts and its inhibition by glucocorticoidsArthritis & Rheumatism, 1993
- Correlation between serum levels of soluble tumor necrosis factor receptor and disease activity in systemic lupus erythematosusArthritis & Rheumatism, 1993
- Tumor necrosis factor α in autoimmunity: pretty girl or old witch?Immunology Today, 1992
- Derivation of the sledai. A disease activity index for lupus patientsArthritis & Rheumatism, 1992
- T Lymphocyte Adhesion to Human Synovial Fibroblasts. Role of Cytokines and the Interaction Between Intercellular Adhesion Molecule 1 and CD11a/CD18Arthritis & Rheumatism, 1991
- Chronic therapy with recombinant tumor necrosis factor-α in autoimmune NZB/NZW F1 miceClinical Immunology and Immunopathology, 1989